Product Images Fenofibric Acid
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Fenofibric Acid NDC 68180-128 by Lupin Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a medication with National Drug Code (NDC) 68180-128-01 that comes in the form of delayed-release capsules containing choline fenofibrate. Each capsule is equivalent to 45 mg of fenofibric acid. The medicine is manufactured by Lupin Pharmaceuticals in Baltimore, MD, and should not be accepted if the seal over the bottle opening is broken or missing. The medication should be stored at 25°C (77°F) and protected from moisture with excursions permitted to 15 to 30°C (59 to 86°F). This is a prescription-only medication with a package insert providing full prescribing information. The package contains 100 capsules, and the size of each one is 54 x 16 mm.*
This is a description of a drug, with the NDC number 68180-129-01, which is a delayed-release capsule containing choline fenofibrate, equivalent to fenofibric acid 135 mg. It is manufactured by Lupin Pharmaceuticals, Inc. and the instructions advise not to accept it if the seal over the bottle opening is broken or missing. This drug should be stored at 25°C with excursions permitted to 15-30°C in a controlled room temperature, and should be protected from moisture. The package insert should be consulted for full prescribing information. The code number is GO/DRUGS/654 and there are 100 capsules included.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.